欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/6434/002
药品名称
Venlafaxina Aurobindo
活性成分
Venlafaxine hydrochloride 75.0 mg
剂型
Prolonged-release capsule, hard
上市许可持有人
Aurobindo Pharma (Portugal), Unip, Lda.
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Venlafaxine Aurobindo 75 mg Hartkapsel, retadiert
Ireland (IE)
France (FR)
Italy (IT)
Poland (PL)
Venlafaxine Aurobindo
Malta (MT)
Venlafaxine Aurobindo 75mg prolonged-release capsules, hard
许可日期
2014/12/27
最近更新日期
2025/05/27
药物ATC编码
N06AX16 venlafaxine
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
PubAR Summary
|
sPAR_NLH6434_Venlafaxine Aurobindo 37_5 mg_ 75 mg and 150 mg_23 July 2025_EN
Date of last change:2025/07/23
PubAR
|
PAR_NLH6434_Venlafaxine Aurobindo 37_5 mg_ 75 mg and 150 mg_23 July 2025
Date of last change:2025/07/23
Final Product Information
|
common_outer
Date of last change:2024/09/06
Final Product Information
|
common_pl_clean
Date of last change:2024/09/06
Final SPC
|
common_SmPC_clean
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase